Abstract:AIMTo investigate a formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis (HL-SAP).METHODSThirty-two consecutive patients with severe acute pancreatitis were included in the clinical trial. All of them met the following five criteria for admission to the study, namely the Atlanta classification and stratification system for the clinical diagnosis of SAP, APACHEII score more than 8, time interval for therapeutic intervention less than 72 hours after onset of the disease, serum triglyceride (TG) level 6.8 mmol/l or over, and exclusion of other etiologies. They were divided into severe acute pancreatitis group (SAP, 22 patients) and fulminant severe acute pancreatitis group (FSAP, 10 patients). Besides the conventional therapeutic measures, Penta-association therapy was also applied in the two groups, which consisted of blood purification (adsorption of triglyceride and hemofiltration), antihyperlipidemic agents (fluvastatin or lipanthyl), low molecular weight heparin (fragmin), insulin, topical application of Pixiao (a traditional Chinese medicine) over the whole abdomen. Serum triglyceride, pro-inflammatory cytokines and anti-inflammatory cytokines were determined before blood purification (PF), at the end of blood purification (AFE) and on the 7th day after onset of the disease (AF7) respectively. Simultaneously, severity of the diseases was assessed by the APACHE II system. PROGNOSIS was evaluated by non-operation cure rate, absorption rate of pseudocyst, time interval pseudocyst absorption, hospital stay and survival rate.RESULTSSerum triglyceride level (mmol/L), TNFalpha (U/ml) concentration and APACHE II score were significantly decreased (P<0.05) at AFE and AF7, as compared with PF. However, serum IL-10 concentration (pg/ml) was increased significantly (P<0.001) at AFE, and decreased significantly (P<0.05) at AF7 when compared with PF.OPERATIONSThe First surgical intervention time was 55.8+/-42.6 days in SAP group (5 patients) and 12.2+/-6.6 days in FSAP group (7 patients), there was a significant difference between the two groups (P=0.02). The number of operations in the two groups was 1.33+/-0.5 vs 3.5+/-1.2 (P=0.0037), respectively.PROGNOSISNon-operation cure rate, absorption rate of pseudocyst, hospital stay and survival rate in SAP group and FSAP group were 100% (22/22) vs 11.1% (1/9), 77.3% (17/22) vs 11.1% (1/9), 54.2+/-35.9 vs 99.1+/-49.5 days (P=0.008) and 100%(22/22) vs 66.7% (6/9) (P=0.0044). The time for absorption of pseudocyst was 135.1+/-137.5 days in SAP group.CONCLUSIONPenta-association therapy is an effective guideline in the treatment of hyperlipidemic severe acute pancreatitis at its early stage (within 72 hours).

[Double Filtration Plasmapheresis in Treatment of Hyperlipidemic Acute Pancreatitis].

Double filtration plasmapheresis for treatment of hyperlipodemia and acute hyperlipodimic pancreatitis

A single-center experience of non-bioartificial DFAPP support systems among Chinese patients with hyperlipidemic moderate/severe acute pancreatitis

Treatment of Refractory Hyperlipidemia Using Double Filtration Plasmapheresis System(DFPP)

Efficiency of Double Plasma Molecular Absorption System on the Acute Severe Cholestatic Hepatitis.

Application of Lipid Apheresis in Acute Lipogenic Pancreatitis

Effect of plasmapheresis versus standard treatment in preventing recurrent acute pancreatitis in Chinese patients with hypertriglyceridemia

Adjunctive Continuous High-Volume Hemofiltration in Patients with Acute Severe Pancreatitis: a Prospective Nonrandomized Study.

Plasma Purification Treatment Relieves the Damage of Hyperlipidemia to PBMCs

Adjunctive Continuous High-Volume Hemofiltration in Acute Severe Pancreatitis Patients: A Retrospective Study

Effects of earlier plasmaphersis combined with Continuous Veno-venous Hemo-filtration in the treatment of hyperlipdemic acute pancreatitis

Effect of Early High Volume Hemofiltration on Patients with Severe Acute Pancreatitis.

Treatment of rejection and highly sensitized in kidney transplantation with double filtration plasmapheresis

Clinical effects of double filtration plasmapheresis for sensitized recipients of cadaver kidney transplantation

Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis

Application of early continuous high-volume-hemofiltration in the treatment of severe acute pancreatitis

Early Plasmapheresis Among Patients With Hypertriglyceridemia–Associated Acute Pancreatitis

Relationship Between Lipid-lowering Therapy on Acute Severe Hyperlipidemic Pancreatitis and Disease Outcome

Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis

Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: a preliminary report

Formalized Therapeutic Guideline for Hyperlipidemic Severe Acute Pancreatitis.